Journal
ONCOTARGET
Volume 8, Issue 52, Pages 89427-89428Publisher
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.20802
Keywords
ribosome; ribosomopathies; RPL5; proteasome inhibitor; bortezomib